Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Prostatic Neoplasms 13Lung Neoplasms 12Carcinoma, Non-Small-Cell Lung 7Breast Neoplasms 7Carcinoma, Renal Cell 6Urinary Bladder Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Neuroblastoma 4Glioblastoma 4Colorectal Neoplasms 4Brain Neoplasms 4Small Cell Lung Carcinoma 3Oropharyngeal Neoplasms 3Neoplasms 3Neoplasm Metastasis 3Mouth Neoplasms 3Melanoma 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Ganglioneuroblastoma 3Disease 3Carcinoma, Hepatocellular 3Carcinoma 3Ureteral Neoplasms 2Rhabdomyosarcoma, Embryonal 2Rhabdomyosarcoma 2Ovarian Neoplasms 2Multiple Myeloma 2Medulloblastoma 2Lymphoma, Mantle-Cell 2

Interventions

Melphalan 8Dexamethasone 7Bortezomib 6Filgrastim 4Cyclophosphamide 3liposomal amphotericin B 2Early Intervention, Educational 2Darbepoetin alfa 2Clinical Protocols 2Calcium Dobesilate 2ferrous sulfate 1ferric gluconate 1dexamethasone acetate 1dexamethasone 21-phosphate 1daratumumab 1birtamimab 1auricularum 1Sucrose 1Stem Cell Transplantation 1Specimen Handling 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Ondansetron 1Morphine 1Magnetic Resonance Spectroscopy 1Ketamine 1Hypericum extract LI 160 1Granulocyte Colony-Stimulating Factor 1Fentanyl 1Epoetin Alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Immunoglobulin Light-chain Amyloidosis × Magnetic Resonance Spectroscopy × Clear all
NCT06022939 2026-05-06

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

SWOG Cancer Research Network

Phase 3 Recruiting
338 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡